التجارب السريرية طلب موعد في مايو كلينيك المواقع، والسفر، والإقامةالبحث 23/07/2022 أظهر المَراجع U.S. News Best Hospitals 2020-21. U.S. News & World Report. http://health.usnews.com/best-hospitals/rankings. Accessed Sept. 23, 2020. Planning and financial services. Mayo Clinic. Feb. 26, 2019. Centers of Excellence. Extracorporeal Life Support Organization. https://www.elso.org/AwardofExcellence/CentersofExcellence.aspx. Accessed Dec. 9, 2020. Best Internal Medicine Programs. U.S. World News & Report. https://www.usnews.com/best-graduate-schools/top-medical-schools/internal-medicine-rankings. Accessed Sept. 23, 2020. Doximity Residency Navigator Internal Medicine Programs. Doximity, Inc. https://residency.doximity.com. Accessed Aug. 20, 2018. Innovative 2-step management strategy utilizing EXIT procedure for a fetus with hypoplastic left heart syndrome and intact atrial septum. Mayo Clinic Proceedings. 2019; doi: 10.1016/j.mayocp.2018.08.004. Gray WS (expert opinion). Mayo Clinic. Oct. 26, 2020. Crestanello JA (expert opinion). Mayo Clinic. Nov. 9, 2020. بالأسفل التجارب السريرية الحالية.24 دراسات في جراحة القلب والأوعية الدموية (افتح الدراسات فقط). غربل قائمة الدراسات هذه بالموقع والحالة وغيرها. Surgical Outcomes of Mitral Valve Repair Rochester, Minn. The purpose of this study is to learn more about early and late outcomes in patients after mitral valve repair. An Open Label Follow-Up Study to Evaluate the Long Term Safety and Efficacy of L-CSA in Patients with a Diagnosis of CLAD-BOS after they have completed participation to BOSTON-1 and BOSTON-2 studies Jacksonville, Fla. The purpose of this study is to assess the long-term effectiveness and safety of L-CsA plus Standard of Care (SoC) in the treatment of BOS in single (SLT) and double lung transplant (DLT) recipients. Enrollment will be limited to patients who have completed 48 weeks participation in either the BT-L-CsA-301-SLT (BOSTON-1) or BT-L-CsA-302-DLT (BOSTON-2) trial. All patients in this clinical trial will receive L-CsA in addition to Standard of Care, regardless of randomization arm in prior trials. A Study to Compare FEIBA to Alternative Blood Products in Treating Children After Cardiac Surgery Rochester, Minn. The purpose of this study is to determine the effectiveness and safety of aPCC FEIBA in children undergoing cardiac surgery with cardiopulmonary bypass. PROACT Xa - A Trial to Determine if Participants With an On-X Aortic Valve Can be Maintained Safely on Apixaban Rochester, Minn. The purpose of this study is to determine if participants with an On-X Prosthetic Heart Valve / On-X aortic valve can be maintained safely and effectively on apixaban. Both the On-X aortic valve and apixaban have been approved for use by the US Food and Drug Administration (FDA) but they have not been approved to be used together. Currently, warfarin is the only approved anticoagulation for patients with mechanical valves. A Study to Evaluate Wellness Coaching for Caregivers of Thoracic Transplant Candidates Rochester, Minn. The purpose of this study is to examine the effects of a health coaching intervention on the stress and burden of caregivers of patients awaiting heart or lung transplant. Hypotheses: Caregivers will have traits and behaviors pre-transplant that will predict caregiver readiness, quality of life, and transplant recipient outcomes. Specifically, thoracic pre-transplant caregivers report stress, symptoms of anxiety or depression, and perceive high caregiver burden. These factors may be amenable to pre-transplant intervention to improve overall patient and caregiver outcomes. Aims, purpose, or objectives: We will conduct a pilot trial to test whether caregivers of heart and lung transplant candidates who receive wellness coaching will experience improvement in caregiver-related distress. We will also explore the relationship between caregiving and factors such as uncertainty, resilience, stress level, and affect. Surveillance HeartCare® Outcomes Registry Rochester, Minn., Scottsdale/Phoenix, Ariz., Jacksonville, Fla. The purpose of this study is to assess the clinical utility of surveillance using HeartCare testing services, in association with clinical care of heart transplant recipients. Prevalence of Transthyretin Cardiac Amyloidosis in Clinically Significant Aortic Stenosis Rochester, Minn. The purpose of this study is to determine the prevalence of TTR-CA in a community-based cohort of moderate and severe aortic stenosis patients using 99mTc-PYP single-photon positive emission computed tomography with computed tomography (SPECT/CT). AtriCure CryoICE Lesions for Persistent and Long-standing Persistent Atrial Fibrillation Treatment Rochester, Minn. The purpose of this study is to evaluate the safety and effectiveness of AtriCure's CryoICE Ablation System in performing the Cox-Maze III Lesion set surgical procedure, in conjunction with LAA exclusion using ArtiCure's AtriClip device. The effectiveness of the device will be demonstrated by establishing that the device effectively eliminates persistent and long-standing persistent atrial fibrillation in a clinically significant proportion of treated patients. A Study to Evaluate the Effectiveness and Safety of D-PLEX in the Prevention of Sternal Infection Post- Cardiac Surgery Rochester, Minn. The purpose of this study is to assess the effectiveness and safety of D-PLEX administered concomitantly over a period of 90 days (3 months)with the standard of care (SOC) IV prophylactic antibiotic treatment vs. SOC in prevention of post-cardiac surgery sternal infections. A Study to Evaluate the GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis in the Treatment of Thoracoabdominal and Pararenal Aortic Aneurysms Rochester, Minn. The purpose of this study is assess the safety and effectiveness of the GORE® EXCLUDER® Thoracoabdominal Branch Endoprost (TAMBE) Device in the treatment of thoracoabdominal and pararenal aortic aneurysms. التصفّح دراسات سريرية توجّه للصفحة 11 توجّه للصفحة 22 توجّه للصفحة 33 التاليالصفحة التالية صُنفت مايو كلينك في روتشستر بولاية مينيسوتا كإحدى أفضل المستشفيات في طب القلب وجراحته حسب بيانات 2021-2022 الصادرة عن U.S. News & World Report. اعرف المزيد عن هذا الشرف الرفيع جراحة القلب والأوعية الدمويةالصفحة الرئيسية للقسمالأقساممُلخّصطلب تحديد موعدالاختبارات والإجراءاتحالات تم علاجهاالأطباءمجموعات التخصصالخبرة و مراتب التصنيفالمواقع، والسفر، والإقامةالتجارب السريريةالبحثتجارب Mayo Clinic وقصص المرضىالتكاليف والتأمينأخبار من Mayo Clinicإحالة المرضى الأبحاث: الأمر برمته يتوقف على المرضى الأقسامطلب تحديد موعدمُلخّصالاختبارات والإجراءاتحالات تم علاجهاالأطباءمجموعات التخصصالخبرة و مراتب التصنيفالمواقع، والسفر، والإقامةالتجارب السريريةالبحثتجارب Mayo Clinic وقصص المرضىالتكاليف والتأمينأخبار من Mayo Clinicإحالة المرضى ORG-20123409 الأقسام والمراكز المراكز والأقسام الطبية جراحة القلب والأوعية الدموية